Prostate cancer cases ( N = 191 ) detected on a for-cause ( clinically indicated ) or end-of-study ( protocol directed ) biopsy , and frequency-matched controls ( N = 209 ) , defined as negative for cancer on an end-of-study biopsy , were sampled from the placebo arm of the Prostate Cancer Prevention Trial .